Greenberg Traurig Hires Ex-FDA Affiliate Chief Litigation Counsel

The logo of the law firm Greenberg Traurig LLP in their Washington, DC, US REUTERS / Andrew Kelly office

  • Before James Fraser joined the FDA in 2016, he was a Venable partner
  • Greenberg Traurig lured the London restructuring leader away from Latham & Watkins on Wednesday

The company and office names listed above are automatically generated from the text of the article. We are improving this feature as we continue to test and develop the beta version. We appreciate your feedback, which you can submit using the feedback tab on the right side of the page.

(Reuters) – Greenberg Sadly announced Thursday that it has brought in a US Food and Drug Administration trial attorney for its health care and litigation.

James Fraser joined Greenberg Traurig as a shareholder after serving five years as the FDA’s Associate Chief Counsel on litigation. Prior to joining the FDA in 2016, Fraser was with Venable for 11 years.

“This was a great landing spot for me. I couldn’t be happier to be sad here at Greenberg,” said Fraser. He will serve in both the firm’s healthcare and FDA practice, as well as litigation.

Fraser has represented the FDA and worked with the US Department of Justice in litigation when companies challenged the agency’s decision-making regarding drugs, medical devices, and other products. He also filed civil enforcement actions against companies that allegedly violated the Food, Drugs and Cosmetics Act.

Returning to his private practice, Fraser hopes to use his FDA experience to advise life science companies, including pharmaceutical and medical device companies, on complex product liability cases or litigation with the agency.

Fraser won’t be around strangers. In May, Greenberg Traurig welcomed one of his former colleagues – Robert Charrow, General Counsel of the US Department of Health – as Senior Chairman of the Health Care & FDA Practice.

Fraser also counts Lori Cohen, the firm’s vice chairman and co-chair of global litigation practice, among her friend, who has served on the same site in drug liability litigation.

Fraser’s departure from the FDA comes three months after his boss, Stacy Cline Amin, former FDA chief attorney during the Trump administration, joined Morrison & Foerster as co-head of FDA regulatory and compliance practice. Amin started this role in June.

Fraser’s arrival at Greenberg Sad comes the day after the announcement of the recruitment of John Houghton, the former global co-chair of Latham’s Restructuring and Special Situations practice and the former European head of the same practice. Houghton is now Chairman of Greenberg Traurig’s London Restructuring and Bankruptcy Practice.

Continue reading:

Morrison & Foerster appoints ex-FDA chief counsel as co-lead of the practice

David Thomas

David Thomas reports on the legal business including law firm strategy, hiring, mergers and litigation. He is based in Chicago. He can be reached at [email protected] and on Twitter @ DaveThomas5150.

Comments are closed.